The use of GLP-1 medications in older adults has yet to be thoroughly studied in prospective clinical trials. Likewise, anyone with baseline osteopenia or osteoporosis may be at risk of a further decrease in bone density and an increased risk of falls and fractures, he added
Rising Demand for Oral and Non-Injectable GLP-1 Formulations The rising demand for oral and non-injectable GLP-1 formulations creates immense opportunities in the market by improving patient convenience and adherence
The delayed gastric emptying caused by semaglutide can lead to feelings of fullness, bloating, and discomfort
They also argued that trying five cases in one trial would save time and money
My identity and personhood could also be tethered to a body and a number, one that would fluctuate but somehow remain an enemy throughout my life
[3] [4] Simultaneously, they suppress glucagon release , which prevents the liver from producing excess glucose